BI Asset Management Fondsmaeglerselskab’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.9M | Sell |
181,413
-124,743
| -41% | -$16.4M | 0.18% | 101 |
|
|
2026
Q1 | $42.7M | Sell |
306,156
-147,311
| -32% | -$20.6M | 0.45% | 41 |
|
|
2025
Q4 | $55.7M | Sell |
453,467
-24,520
| -5% | -$2.98M | 0.49% | 37 |
|
|
2025
Q3 | $53.1M | Sell |
477,987
-60,982
| -11% | -$6.93M | 0.48% | 43 |
|
|
2025
Q2 | $59.8M | Buy |
538,969
+140,158
| +35% | +$14.9M | 0.59% | 33 |
|
|
2025
Q1 | $44.7M | Sell |
398,811
-67,695
| -15% | -$6.99M | 0.5% | 36 |
|
|
2024
Q4 | $43.1M | Buy |
466,506
+319,498
| +217% | +$28.8M | 0.45% | 40 |
|
|
2024
Q3 | $12.3M | Buy |
147,008
+31,652
| +27% | +$2.42M | 0.21% | 92 |
|
|
2024
Q2 | $7.92M | Sell |
115,356
-553,846
| -83% | -$37M | 0.13% | 150 |
|
|
2024
Q1 | $49M | Buy |
669,202
+19,969
| +3% | +$1.54M | 0.92% | 25 |
|
|
2023
Q4 | $52.6M | Buy |
649,233
+42,826
| +7% | +$3.33M | 1.12% | 18 |
|
|
2023
Q3 | $45.4M | Sell |
606,407
-15,689
| -3% | -$1.21M | 1.06% | 20 |
|
|
2023
Q2 | $47.9M | Buy |
622,096
+129,535
| +26% | +$10.3M | 1.14% | 16 |
|
|
2023
Q1 | $40.9M | Sell |
492,561
-7,193
| -1% | -$596K | 1.08% | 15 |
|
|
2022
Q4 | $42.9M | Buy |
499,754
+404,031
| +422% | +$32M | 1.14% | 17 |
|
|
2022
Q3 | $5.91M | Sell |
95,723
-46,770
| -33% | -$2.95M | 0.3% | 79 |
|
|
2022
Q2 | $8.81M | Sell |
142,493
-81,728
| -36% | -$5.06M | 0.38% | 69 |
|
|
2022
Q1 | $13.3M | Buy |
224,221
+3,495
| +2% | +$223K | 0.51% | 59 |
|
|
2021
Q4 | $16M | Sell |
220,726
-20,866
| -9% | -$1.44M | 0.59% | 57 |
|
|
2021
Q3 | $16.9M | Buy |
241,592
+103,267
| +75% | +$7.25M | 0.64% | 47 |
|
|
2021
Q2 | $9.53M | Sell |
138,325
-14,802
| -10% | -$988K | 0.37% | 73 |
|
|
2021
Q1 | $9.9M | Buy |
153,127
+7,337
| +5% | +$473K | 0.4% | 69 |
|
|
2020
Q4 | $8.49M | Buy |
145,790
+43,953
| +43% | +$2.65M | 0.37% | 72 |
|
|
2020
Q3 | $6.43M | Buy |
101,837
+11,807
| +13% | +$819K | 0.29% | 78 |
|
|
2020
Q2 | $6.93M | Sell |
90,030
-110,741
| -55% | -$8.49M | 0.36% | 67 |
|
|
2020
Q1 | $15M | Sell |
200,771
-96,311
| -32% | -$6.65M | 0.89% | 38 |
|
|
2019
Q4 | $19.3M | Sell |
297,082
-224,152
| -43% | -$14.6M | 0.91% | 37 |
|
|
2019
Q3 | $33M | Sell |
521,234
-254,609
| -33% | -$16.6M | 1.62% | 19 |
|
|
2019
Q2 | $52.4M | Buy |
775,843
+263,581
| +51% | +$17.3M | 2.49% | 8 |
|
|
2019
Q1 | $33.3M | Buy |
512,262
+237,512
| +86% | +$15.8M | 1.68% | 14 |
|
|
2018
Q4 | $17.2M | Sell |
274,750
-40,900
| -13% | -$2.86M | 1.1% | 38 |
|
|
2018
Q3 | $24.4M | Buy |
315,650
+304,350
| +2,693% | +$23M | 1.52% | 21 |
|
|
2018
Q2 | $800K | Buy |
+11,300
| New | +$798K | 0.06% | 75 |
|
Other funds holding GILD
BI Asset Management Fondsmaeglerselskab's GILD Position: Q2 2026 in Review
BI Asset Management Fondsmaeglerselskab reduced its Gilead Sciences (GILD) stake by 41% in Q2 2026, selling an estimated $16.4M and leaving 181,413 shares worth $22.9M. The position accounts for 0.18% of the portfolio, ranked #101.
BI Asset Management Fondsmaeglerselskab first reported a position in GILD in Q2 2018 and has held it in 33 quarters since. The position peaked at $59.8M in Q2 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab held 181,413 shares of Gilead Sciences worth $22.9M as of Q2 2026.
- BI Asset Management Fondsmaeglerselskab sold 124,743 Gilead Sciences shares in Q2 2026, an estimated $16.4M.
- Gilead Sciences made up 0.18% of BI Asset Management Fondsmaeglerselskab's portfolio in Q2 2026, its #101 holding.
- BI Asset Management Fondsmaeglerselskab first reported a position in Gilead Sciences in Q2 2018 and has held it in 33 quarters since.
- BI Asset Management Fondsmaeglerselskab's Gilead Sciences position peaked at $59.8M in Q2 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q2 2026, filed 10 Aug 2026.